BIOSYM A/S: Financial statements 2022
CVR: 21774189
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 12,990,839 and a net result of DKK 2,110,000 compared with DKK 7,108,011 the year before. That is a decrease of 30.3% compared with the year before. Equity in the 2022 report amounted to DKK 29,858,736. The solvency ratio was 41.7%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 12,990,839
- Profit/Loss
- DKK 2,110,000
- Equity
- DKK 29,858,736
- Total Assets
- DKK 71,572,929
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 13 mio. | 2.1 mio. | 29.9 mio. | 18 |
| 2021 | - | 18.6 mio. | 7.1 mio. | 27.7 mio. | 18 |
| 2020 | - | 18 mio. | 6.7 mio. | 20.6 mio. | 19 |
| 2018 | - | 14.8 mio. | 6 mio. | 14.5 mio. | 19 |
| 2017 | - | 11.6 mio. | 2.8 mio. | 12.5 mio. | 17 |
Official annual report
Keep an eye on BIOSYM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BIOSYM A/S has published its annual report for 2021. Gross profit came to DKK 18,635,215, and the net result was DKK 7,108,011.
About BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.